Skip to main content
. 2022 Jul 22;13:938985. doi: 10.3389/fgene.2022.938985

TABLE 1.

Clinicopathological characteristics of six ovarian cancer patients that were treated with neoadjuvant chemotherapy.

Case no. Age (Year) FIGO stage Right (R) and left (L) ovary Histological diagnosis Treatment Clinical response to therapy
1 38 III R HGSOC Carboplatin + paclitaxel Progressive disease
2 78 IV R HGSOC Carboplatin + paclitaxel Responsive
3 45 II R HGSOC Carboplatin + paclitaxel Responsive
4 50 III R and L HGSOC Carboplatin + paclitaxel Progressive disease
5 54 III R and L HGSOC Carboplatin + paclitaxel Progressive disease (death)
6 68 IV R HGSOC Carboplatin + paclitaxel Progressive disease (death)